These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34155594)

  • 1. The First Case of Immunity Loss and SARS-CoV-2 Reinfection by the Same Virus Lineage in Amazonia.
    Ferrante L; Livas S; Steinmetz WA; Almeida ACL; Leão J; Vassão RC; Tupinambás U; Fearnside PM; Duczmal LH
    J Racial Ethn Health Disparities; 2021 Aug; 8(4):821-823. PubMed ID: 34155594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies.
    Brehm TT; Pfefferle S; von Possel R; Kobbe R; Nörz D; Schmiedel S; Grundhoff A; Olearo F; Emmerich P; Robitaille A; Günther T; Braun P; Andersen G; Knobloch JK; Addo MM; Lohse AW; Aepfelbacher M; Fischer N; Schulze Zur Wiesch J; Lütgehetmann M
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33921216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil.
    Romano CM; Felix AC; Paula AV; Jesus JG; Andrade PS; Cândido D; Oliveira FM; Ribeiro AC; Silva FCD; Inemami M; Costa AA; Leal COD; Figueiredo WM; Pannuti CS; Souza WM; Faria NR; Sabino EC
    Rev Inst Med Trop Sao Paulo; 2021; 63():e36. PubMed ID: 33909850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster.
    Brustolin M; Rodon J; Rodríguez de la Concepción ML; Ávila-Nieto C; Cantero G; Pérez M; Te N; Noguera-Julián M; Guallar V; Valencia A; Roca N; Izquierdo-Useros N; Blanco J; Clotet B; Bensaid A; Carrillo J; Vergara-Alert J; Segalés J
    Emerg Microbes Infect; 2021 Dec; 10(1):797-809. PubMed ID: 33825619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.
    Borgogna C; De Andrea M; Griffante G; Lai A; Bergna A; Galli M; Zehender G; Castello L; Ravanini P; Cattrini C; Mennitto A; Gennari A; Gariglio M
    J Med Virol; 2021 Dec; 93(12):6444-6446. PubMed ID: 34260066
    [No Abstract]   [Full Text] [Related]  

  • 6. Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape.
    Rani PR; Imran M; Lakshmi JV; Jolly B; Jain A; Surekha A; Senthivel V; Chandrasekhar P; Divakar MK; Srinivasulu D; Bhoyar RC; Vanaja PR; Scaria V; Sivasubbu S
    J Med Virol; 2021 Jul; 93(7):4163-4165. PubMed ID: 33818797
    [No Abstract]   [Full Text] [Related]  

  • 7. Reinfections, still rare, provide clues on immunity.
    de Vrieze J
    Science; 2020 Nov; 370(6519):895-897. PubMed ID: 33214256
    [No Abstract]   [Full Text] [Related]  

  • 8. Dynamics of COVID-19 in Amazonia: A history of government denialism and the risk of a third wave.
    Ferrante L; Duczmal LH; Capanema E; Steinmetz WAC; Almeida ACL; Leão J; Vassão RC; Fearnside PM; Tupinambás U
    Prev Med Rep; 2022 Apr; 26():101752. PubMed ID: 35242505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brazil's COVID-19 Epicenter in Manaus: How Much of the Population Has Already Been Exposed and Are Vulnerable to SARS-CoV-2?
    Ferrante L; Duczmal LH; Steinmetz WA; Almeida ACL; Leão J; Vassão RC; Tupinambás U; Fearnside PM
    J Racial Ethn Health Disparities; 2022 Dec; 9(6):2098-2104. PubMed ID: 34590244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response variables and viral mutations impact on COVID-19 reinfection and relapse.
    Sanaie S; Golipour E; Shamekh A; Sadaie MR; Mahmoodpoor A; Yousefi M
    Int Immunopharmacol; 2021 Nov; 100():108108. PubMed ID: 34521025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.
    Silva MSD; Demoliner M; Hansen AW; Gularte JS; Silveira F; Heldt FH; Filippi M; Pereira VMAG; Silva FPD; Mallmann L; Fink P; Silva LLD; Weber MN; Almeida PR; Fleck JD; Spilki FR
    Rev Inst Med Trop Sao Paulo; 2021; 63():e58. PubMed ID: 34231823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinfection cases by closely related SARS-CoV-2 lineages in Southern Brazil.
    Gularte JS; da Silva MS; Demoliner M; Hansen AW; Heldt FH; Silveira F; Filippi M; Pereira VMAG; da Silva FP; Mallmann L; Fink P; Laux JL; Weber MN; de Almeida PR; Fleck JD; Spilki FR
    Braz J Microbiol; 2021 Dec; 52(4):1881-1885. PubMed ID: 34562232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between Antibody Levels and SARS-Cov-2 Reinfection.
    Islamoglu MS; Cengiz M; Uysal BB; Ikitimur H; Ozdemir Z; Karamehmetoglu A; Akbulut AE; Bakdur AN; Ozdemir A; Kayıkcıoglu H; Ozdemir H; Uces R; Ersoy S; Yavuzer S
    Ann Clin Lab Sci; 2021 Nov; 51(6):750-755. PubMed ID: 34921027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A first probable case of SARS-CoV-2 reinfection in Colombia.
    Novoa W; Miller H; Mattar S; Faccini-Martínez ÁA; Rivero R; Serrano-Coll H
    Ann Clin Microbiol Antimicrob; 2021 Jan; 20(1):7. PubMed ID: 33435982
    [No Abstract]   [Full Text] [Related]  

  • 15. Modelling of Waning of Immunity and Reinfection Induced Antibody Boosting of SARS-CoV-2 in Manaus, Brazil.
    Wei H; Musa SS; Zhao Y; He D
    Int J Environ Res Public Health; 2022 Feb; 19(3):. PubMed ID: 35162752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to glycan α-Gal and possibilities for the control of COVID-19.
    la Fuente J; Gortázar C; Cabezas-Cruz A
    Immunotherapy; 2021 Feb; 13(3):185-188. PubMed ID: 33307805
    [No Abstract]   [Full Text] [Related]  

  • 17. High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.
    Lalwani P; Araujo-Castillo RV; Ganoza CA; Salgado BB; Pereira Filho IV; da Silva DSS; de Morais TBDN; Jordão MF; Ortiz JV; Barbosa ARC; Sobrinho WBS; Cordeiro IB; de Souza Neto JN; de Assunção EN; da Costa CF; de Souza PE; de Albuquerque BC; Astofi-Filho S; ; Lalwani JDB
    Lancet Glob Health; 2021 Nov; 9(11):e1508-e1516. PubMed ID: 34678195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.
    Tang CY; Wang Y; McElroy JA; Li T; Hammer R; Ritter D; Lidl GM; Webby R; Hang J; Wan XF
    J Med Virol; 2021 Oct; 93(10):5700-5703. PubMed ID: 34170528
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 reinfection in a healthcare professional in inner Sao Paulo during the first wave of COVID-19 in Brazil.
    Camargo CH; Gonçalves CR; Pagnoca EVRG; Campos KR; Montanha JOM; Flores MNP; Soares MMCN; Binhardi FMT; Ferreira PM; Yu ALF; Carvalhanas TRMP; Abbud A; Bugno A; Sacchi CT
    Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115516. PubMed ID: 34425504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.
    Yang Y; Wang X; Du RH; Zhang W; Si HR; Zhu Y; Shen XR; Li Q; Li B; Men D; Zhou YN; Wang H; Tong XL; Zhang XE; Shi ZL; Zhou P
    Emerg Microbes Infect; 2021 Dec; 10(1):905-912. PubMed ID: 33870851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.